IntroGene: Over the manufacturing hurdle

Netherlands Emerging Company Profile

One of the roadblocks to development of adenovirus and adeno-associated virus as gene therapy vectors has been manufacturing. For adenovirus, the problem has been difficulty in manufacturing vectors free from contamination by replication-competent adenovirus. For adeno-associated virus, the issue has been the lack of a stable packaging cell line.

One company that believes it has solved the problems is

Read the full 637 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE